1.
Motomiya Y, Kaneko Y, Motomiya Y, Higashimoto Y. Serum Levels of the C-terminal Fragment of Fibroblast Growth Factor 23 (C-FGF23) and Hepcidin in Patients with Hemodialysis Undergoing Treatment with a Proline Hydroxylase Domain (PHD) Inhibitor. J Clini Nephrol [Internet]. 2024 Oct. 14 [cited 2025 Jul. 10];8(3):132-7. Available from: https://www.clinnephrologyjournal.com/jcn/article/view/jcn-aid1141